HKG Equity Snapshot

1541 Weekly Equity Report

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Interactive chart JSON snapshot
Latest Close 3.61 HKD 12 Jun 2026
1W Return 13.9% latest completed week
4W Return 2.6% short-term follow-through
12W Return -23.5% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

ImmuneOnco Biopharmaceuticals (Shanghai) Inc., a biotechnology company, engages in the research and development of immuno-oncology therapies in China and the United States. The company's core product candidate is IMM01, which is in Phase Ib/IIa clinical trial to evaluate the combination with bortezomib and dexamethasone for the treatment of multiple myeloma; Phase II clinical trial in combination with azacitidine for the first-line treatment of higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia; and Phase III clinical trial in combination with tislelizumab, targeting relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) patients who relapsed or progressed after the …

Snapshot

What the weekly tape is saying

1541 closed the latest completed week at 3.61 HKD. The 4-week return is 2.6% and the 12-week return is -23.5%. Trend Signal is inactive, Market Dynamics is -0.10. Setup signature: Risk-first tape with a 21/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -27.7%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 20 Persistence of active Trend Signal over the last year and current streak.
Momentum 35 Blend of 4-week and 12-week follow-through.
Dynamics 38 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 35 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
4.99 HKD
Vs Trend Line
-27.7%
Fair Value
11.78 HKD
Vs Fair Value
-69.4%
52W High
16.80 HKD
52W Low
2.80 HKD
Drawdown
-78.5%
Range Position
5.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 13.9%
4W 2.6%
12W -23.5%
26W -44.5%
52W -72.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
19
52W Active Breadth
36.5%
Sector Scope
HK Healthcare
Sector Rank
6 of 257
Sector Percentile
98.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.10
4W MD Change
-124.4%
Relative Strength
-51.11
4W RS Change
13.1%
Expectation
Negative
Probability
42.88%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
7.2M
13W Average
8.6M
52W Average
11.5M
Vs 13W
0.8x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
11.8%
52W Volatility
12.1%
Upside Weeks
18
Downside Weeks
34
Downside Breadth
65.4%
Avg Gain / Loss
11.3% / -8.7%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
1.3B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 3.61 HKD 13.9% 4.99 HKD 11.78 HKD -0.10 -51.11 7.2M Off
5 Jun 2026 3.17 HKD 8.2% 5.14 HKD 11.84 HKD -0.04 -58.58 21.8M Off
29 May 2026 2.93 HKD -14.1% 5.29 HKD 11.90 HKD 0.01 -63.13 7.3M Off
22 May 2026 3.41 HKD -3.1% 5.50 HKD 11.96 HKD 0.21 -58.89 4.4M Off
15 May 2026 3.52 HKD -16.2% 5.69 HKD 12.02 HKD 0.42 -58.81 9.6M Off
8 May 2026 4.20 HKD -9.9% 5.92 HKD 12.08 HKD 0.66 -52.11 6.4M Off
1 May 2026 4.66 HKD -7.9% 6.20 HKD 12.14 HKD 0.58 -45.97 3.6M Off
24 Apr 2026 5.06 HKD -14.8% 6.56 HKD 12.19 HKD 0.54 -42.13 7.4M Off
17 Apr 2026 5.94 HKD 25.3% 6.77 HKD 12.24 HKD 0.35 -33.03 14.3M Off
10 Apr 2026 4.74 HKD -0.2% 6.98 HKD 12.29 HKD 0.16 -46.03 3.0M Off
3 Apr 2026 4.75 HKD 6.5% 7.23 HKD 12.35 HKD 0.18 -44.46 8.3M Off
27 Mar 2026 4.46 HKD -5.5% 7.53 HKD 12.40 HKD 0.04 -47.80 3.3M Off
20 Mar 2026 4.72 HKD -3.5% 7.75 HKD 12.46 HKD -0.12 -45.65 15.8M Off
13 Mar 2026 4.89 HKD 10.4% 7.99 HKD 12.52 HKD -0.49 -44.14 9.6M Off